Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
+$464M |
| 2 |
Exxon Mobil
XOM
|
+$299M |
| 3 |
FedEx
FDX
|
+$289M |
| 4 |
Netflix
NFLX
|
+$273M |
| 5 |
Micron Technology
MU
|
+$265M |
Top Sells
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$285M |
| 3 |
Mastercard
MA
|
+$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
1826
DELISTED
Cymabay Therapeutics
CBAY
| $4.6M | 0.01% |
570,200
+256,808
| +82% | +$2.07M |
|
1827
Genesco
GCO
$362M
| $4.59M | 0.01% |
172,700
+19,600
| +13% | +$521K |
|
|
KDNY
1828
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.59M | 0.01% |
86,180
+35,440
| +70% | +$1.89M |
|
1829
First Northwest Bancorp
FNWB
$64.9M
| $4.57M | 0.01% |
267,100
+12,100
| +5% | +$207K |
|
1830
Independence Realty Trust
IRT
$4.02B
| $4.56M | 0.01% |
448,395
+213,495
| +91% | +$2.17M |
|
1831
Travelzoo
TZOO
$106M
| $4.56M | 0.01% |
530,000
+35,900
| +7% | +$309K |
|
|
HK
1832
DELISTED
Halcon Resources Corporation
HK
| $4.55M | 0.01% |
+668,400
| New | +$4.55M |
|
|
LABL
1833
DELISTED
Multi-Color Corp
LABL
| $4.54M | 0.01% |
55,400
+41,500
| +299% | +$3.4M |
|
|
OMCC
1834
Old Market Capital Corporation Common Stock
OMCC
$34.6M
| $4.53M | 0.01% |
522,929
-7,400
| -1% | -$64.2K |
|
|
PNTR
1835
DELISTED
Pointer Telocation Ltd.
PNTR
| $4.52M | 0.01% |
266,700
+47,060
| +21% | +$798K |
|
1836
Innospec
IOSP
$2B
| $4.5M | 0.01% |
73,000
-21,000
| -22% | -$1.29M |
|
|
NSTG
1837
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.5M | 0.01% |
278,400
-99,900
| -26% | -$1.61M |
|
1838
Daktronics
DAKT
$1.17B
| $4.49M | 0.01% |
424,648
+131,948
| +45% | +$1.39M |
|
|
EDN
1839
Edenor
EDN
$731M
| $4.47M | 0.01% |
112,500
+59,100
| +111% | +$2.35M |
|
|
PMBC
1840
DELISTED
Pacific Mercantile Bancorp
PMBC
| $4.47M | 0.01% |
488,700
+20,300
| +4% | +$186K |
|
1841
Amtech Systems
ASYS
$133M
| $4.46M | 0.01% |
371,923
+242,787
| +188% | +$2.91M |
|
|
YRD
1842
Yiren Digital
YRD
$520M
| $4.44M | 0.01% |
105,900
-100,100
| -49% | -$4.2M |
|
|
PBNC
1843
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $4.43M | 0.01% |
78,391
+49,726
| +173% | +$2.81M |
|
|
FARO
1844
DELISTED
Faro Technologies
FARO
| $4.42M | 0.01% |
115,600
-87,400
| -43% | -$3.34M |
|
1845
Build-A-Bear
BBW
$996M
| $4.42M | 0.01% |
483,138
+34,838
| +8% | +$319K |
|
|
AMBR
1846
DELISTED
Amber Road, Inc.
AMBR
| $4.42M | 0.01% |
575,510
-4,095
| -0.7% | -$31.5K |
|
|
PLPM
1847
DELISTED
Planet Payment, Inc
PLPM
| $4.4M | 0.01% |
1,026,500
+116,900
| +13% | +$502K |
|
|
CVG
1848
DELISTED
Convergys
CVG
| $4.39M | 0.01% |
169,700
+113,170
| +200% | +$2.93M |
|
1849
ATI
ATI
$10.7B
| $4.39M | 0.01% |
+183,792
| New | +$4.39M |
|
|
EPZM
1850
DELISTED
Epizyme, Inc
EPZM
| $4.39M | 0.01% |
230,388
+29,600
| +15% | +$564K |
|